TCL Archive ACC Survey Preliminary Finding: Three Cancer DRG Categories “Clearly Underpaid Across The Board” January 25, 1985
TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive Also Cancer policy board urges NCI to convene panel on long-term care for childhood cancer survivors. October 10, 2003